Science Explorer Back to mapMap
Discussion
Researcher · Mie University · Japan

Tadanobu Shimura

Tadanobu Shimura publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Inflammatory Biomarkers in Disease Prognosis, Colorectal Cancer Surgical Treatments and Gastric Cancer Management and Outcomes.

ORCID 0009-0005-6823-1475 OpenAlex
World rank
#1,377,763
of 7,710,434 ranked researchers
Rank in Japan
#21,206
of 383,136
Works
158
Citations
2.1k
Citations per work
13.2
h-index
26
i10-index 50Top 15% in Oncology
Tadanobu Shimura

What does Tadanobu Shimura research?

Tadanobu Shimura's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (16%).

Health Sciences: 79 works · 50.0% of their workMedicine: 79 works · 50.0% of their workOncology: 30 works · 19.0% of their workSurgery: 26 works · 16.7% of their workPulmonary and Respiratory Medicine: 15 works · 9.6% of their workPhysiology: 7 works · 4.7% of their workEverything else: 53 works · 33.8% of their workLife Sciences: 26 works · 16.2% of their workBiochemistry, Genetics and Molecular Biology: 26 works · 16.2% of their workCancer Research: 14 works · 8.9% of their workMolecular Biology: 12 works · 7.3% of their workTHEIR WORKTadanobu Shimura158works
Life Sciences16%Health Sciences50%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine7950.0%
  2. Everything else5333.8%
    1. Biochemistry, Genetics and Molecular Biology2616.2%
  1. 1Oncology19% of their works
  2. 2Surgery17% of their works
  3. 3Pulmonary and Respiratory Medicine10% of their works
  4. 4Cancer Research9% of their works
  5. 5Molecular Biology7% of their works
  6. 6Physiology5% of their works

Research topics

Which keywords describe Tadanobu Shimura's research?

The keywords of their largest research topics: Clinical Practice Guidelines, Inflammation, Cancer, Neoadjuvant Therapy, Preoperative Chemoradiotherapy, Endoscopic Resection, Immunity and Neutrophil-to-Lymphocyte Ratio.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. Clinical Practice Guidelines462 topics
  2. Inflammation442 topics
  3. Cancer432 topics
  4. Neoadjuvant Therapy372 topics
  5. Preoperative Chemoradiotherapy372 topics
  6. Endoscopic Resection352 topics
  7. Immunity281 topic
  8. Neutrophil-to-Lymphocyte Ratio281 topic
  9. Epidemiology252 topics
  10. Adjuvant Chemotherapy241 topic
  11. Rectal Cancer241 topic
  12. Chemotherapy221 topic
  13. Gastric Cancer221 topic
  14. Cancer Cachexia161 topic
  15. Sarcopenia161 topic
  16. Fatty Acid Synthase151 topic
  17. Lipid Metabolism151 topic
  18. Barrett's Esophagus131 topic
  19. Esophageal Carcinoma131 topic
  20. ANGPTL3121 topic
  21. Crohn's Disease121 topic
  22. Inflammatory Bowel Disease121 topic
  23. Lipoprotein Lipase121 topic

Where does Tadanobu Shimura work?

Tadanobu Shimura's main affiliation in the publication record is Mie University, Japan.

How many publications and citations does Tadanobu Shimura have?

OpenAlex counts 158 works and 2,079 citations for Tadanobu Shimura, an h-index of 26, ranking #1,377,763 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Tadanobu Shimura. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.